已收盘 05-22 16:00:00 美东时间
+2.040
+15.80%
Lionsgate Studios Corp. (($LION)) has held its Q4 earnings call. Read on for th...
05-23 08:03
Zoom Communications Inc shares rise after strong financial results and increased buyback authorization. Other big gainers include IMRX, INFQ, ASMB, IMAX, RGTI, HLIT, DELL, EL, GSIT, ELVR, and HPQ.
05-22 22:04
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Lionsgate业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **整体业绩表现:** - 营收:9.07亿美元,同比下降(管理层称为"预期内"的下降) - 调整后OIBDA:1.65亿美元,同比增长17%,创12年来最高水平 - 营业收入:1.18亿美元,同比增长超50% - 每股收益:稀释后每股收益0.23美元;调整后稀释每股收益0.37美元 - 自由现金流:正1.9亿美元,管理层称为"强劲"表现 **分部门业绩:** - 工作室分部利润:2.18亿美元,同比增长24% - 电影业务营收:6.52亿美元,同比增长23%;分部利润
05-22 12:05
Lionsgate Studios (NASDAQ:LION) released fourth-quarter financial results and h...
05-22 05:51
Lionsgate Studios (NASDAQ:LION) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate of $0.24 by 54.17 percent. This is a 76.19 percent increase over earnings of $0.21 per share from
05-22 04:22
Companies Reporting Before The Bell • Cato (NYSE:CATO) is projected to report e...
05-21 19:11
今日重点评级关注:Piper Sandler:维持Aclaris Therapeutics"超配"评级,目标价从7美元升至11美元;Evercore ISI集团:维持BioMarin Pharmaceutical"跑赢大市"评级,目标价从110美元升至120美元
05-06 11:29
Baird analyst Vikram Kesavabhotla maintains Lionsgate Studios (NYSE:LION) with a Outperform and raises the price target from $14 to $16.
05-05 20:09
今日重点评级关注:Benchmark:维持史密斯微软件"买入"评级,目标价从2美元升至2.5美元;Citizens:维持DBV Technologies"跑赢大市"评级,目标价从47美元升至55美元
05-04 16:04
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从48美元升至49美元;Chardan Capital:维持Intellia Therapeutics"买入"评级,目标价从27美元升至30美元
04-28 10:07